Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions News feed Embed this list Save this search Mark all Export Your filters: cql: author="BEEX, L" or (type exact bookEditor and editor="BEEX, L") Mark journalArticle A1 Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer R PARIDAENS, L DIRIX, C LOHRISCH, L BEEX, M NOOIJ, D CAMERON, L BIGANZOLI, T CUFER, Luc Duchateau (UGent) , A HAMILTON, et al. (2003) ANNALS OF ONCOLOGY. 14(9). p.1391-1398 Mark conference C3 Combined treatment with the LHRH-agonist buserelin (LHRH-A) and tamoxifen (TAM) vs single treatment with each drug alone in premenopausal metastatic breast cancer. Final results of EORTC study 10881 JGM KLIJN, L BEEX, L MAURIAC, J VAN ZIJL, C VEYRET, J WILDIERS, J JASSEM, J BURGHOUTS, M PICCART, F MIGNOLET, et al. (1998) ANNALS OF ONCOLOGY. 9. p.11-11 Mark conference C3 A new standard treatment for advanced premenopausal breast cancer: A meta-analysis of the combined hormonal agent trialists group (CHAT) JGM KLIJN, RW BLAMEY, F BOCCARDO, T TOMINAGA, W JONAT, M KAUFMANN, L BEEX, L MAURIAC, G HOCTIN-BOES, Luc Duchateau (UGent) , et al. (1998) EUROPEAN JOURNAL OF CANCER. 34.